Cargando…
The effect of do‐it‐yourself real‐time continuous glucose monitoring on psychological and glycemic variables in children with type 1 diabetes: A randomized crossover trial
BACKGROUND: Continuous glucose monitoring (CGM) decreases fear of hypoglycemia (FOH) and improves glycemic control among those affected by type 1 diabetes (T1D). No studies to date have examined the impact of using do‐it‐yourself real‐time continuous glucose monitoring (DIY RT‐CGM) on psychological...
Autores principales: | Elbalshy, Mona M., Styles, Sara, Haszard, Jillian J., Galland, Barbara C., Crocket, Hamish, Jefferies, Craig, Wiltshire, Esko, Tomlinson, Paul, de Bock, Martin I., Wheeler, Benjamin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons A/S
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314709/ https://www.ncbi.nlm.nih.gov/pubmed/35253331 http://dx.doi.org/10.1111/pedi.13331 |
Ejemplares similares
-
Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta‐analysis of randomised controlled trials
por: Elbalshy, Mona, et al.
Publicado: (2022) -
The OPTIMISE study protocol: a multicentre optimisation trial comparing continuous glucose monitoring, snacking habits, sleep extension and values-guided self-care interventions to improve glucose time-in-range in young people (13–20 years) with type 1 diabetes
por: Rose, Shelley, et al.
Publicado: (2022) -
A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: a 12-week randomised controlled trial protocol
por: Styles, Sara, et al.
Publicado: (2021) -
Good glycemic control without exceeding the BMI trajectory during the first 5 years of treatment in children and adolescents with type 1 diabetes
por: Grönberg, Annika, et al.
Publicado: (2022) -
Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial
por: Forlenza, Gregory P., et al.
Publicado: (2022)